Share Twitter LinkedIn Facebook Email Maxine Sun, PhD, MPH of Dana-Farber Cancer Institute discusses the Utility Pitfalls and Perils of Using Secondary Data for RCC Research at the 2017 annual Kidney Cancer Association Symposium in Miami, FL.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read